Home Arranta Bio

Arranta Bio

acquired
Series B
Contract Development and Manufacturing Organization (CDMO)

Basic Information

Arranta Bio provides contract development and manufacturing services to pioneering innovators, focusing on new therapies for diseases associated with the human microbiome. The company aims to support trailblazers in healthcare therapies for biotherapeutic products (LBP) targeting gut health and microbiome-related diseases by offering development and production services to deliver effective treatments to the market and patients in need.
Arranta Bio Holdings LLC.
Massachusetts,United States of America
51~100 people
January 01, 2019
info@arrantabio.com